Correlation Between Viracta Therapeutics and OnKure Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Viracta Therapeutics and OnKure Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viracta Therapeutics and OnKure Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viracta Therapeutics and OnKure Therapeutics,, you can compare the effects of market volatilities on Viracta Therapeutics and OnKure Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viracta Therapeutics with a short position of OnKure Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viracta Therapeutics and OnKure Therapeutics,.
Diversification Opportunities for Viracta Therapeutics and OnKure Therapeutics,
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between Viracta and OnKure is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Viracta Therapeutics and OnKure Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OnKure Therapeutics, and Viracta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viracta Therapeutics are associated (or correlated) with OnKure Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OnKure Therapeutics, has no effect on the direction of Viracta Therapeutics i.e., Viracta Therapeutics and OnKure Therapeutics, go up and down completely randomly.
Pair Corralation between Viracta Therapeutics and OnKure Therapeutics,
Given the investment horizon of 90 days Viracta Therapeutics is expected to generate 1.14 times more return on investment than OnKure Therapeutics,. However, Viracta Therapeutics is 1.14 times more volatile than OnKure Therapeutics,. It trades about -0.02 of its potential returns per unit of risk. OnKure Therapeutics, is currently generating about -0.05 per unit of risk. If you would invest 76.00 in Viracta Therapeutics on October 6, 2024 and sell it today you would lose (54.00) from holding Viracta Therapeutics or give up 71.05% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Viracta Therapeutics vs. OnKure Therapeutics,
Performance |
Timeline |
Viracta Therapeutics |
OnKure Therapeutics, |
Viracta Therapeutics and OnKure Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Viracta Therapeutics and OnKure Therapeutics,
The main advantage of trading using opposite Viracta Therapeutics and OnKure Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viracta Therapeutics position performs unexpectedly, OnKure Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OnKure Therapeutics, will offset losses from the drop in OnKure Therapeutics,'s long position.Viracta Therapeutics vs. Vincerx Pharma | Viracta Therapeutics vs. Rallybio Corp | Viracta Therapeutics vs. Tenaya Therapeutics | Viracta Therapeutics vs. Lyra Therapeutics |
OnKure Therapeutics, vs. Vaccinex | OnKure Therapeutics, vs. Vigil Neuroscience | OnKure Therapeutics, vs. Viracta Therapeutics | OnKure Therapeutics, vs. Dogwood Therapeutics, |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |